|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7374 USD | -3.98% |
|
-6.81% | -36.43% |
| 07-21 | Rein Therapeutics Completes Global Expansion of Phase 2 IPF Trial | MT |
| 07-20 | Rein Therapeutics Inc. - Shareholder/Analyst Call |
| Market Cap | 68.61M 59.64M 55.51M 50.97M 96.25M 6.55B 97.74M 654M 257M 3.26B 258M 252M 10.93B | P/E 2026 * |
-1.68x | P/E 2027 * | -1.8x |
|---|---|---|---|---|---|
| Enterprise Value | 68.61M 59.64M 55.51M 50.97M 96.25M 6.55B 97.74M 654M 257M 3.26B 258M 252M 10.93B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
94.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Rein Therapeutics Inc.
| 1 day | -3.98% | ||
| 1 week | -6.81% | ||
| 1 month | -24.60% | ||
| 3 months | -28.41% | ||
| 6 months | -43.28% | ||
| Current year | -36.43% |
| 1 week | 0.73 |  | 0.83 |
| 1 month | 0.73 | | 1.05 |
| Current year | 0.73 | | 2.1 |
| 1 year | 0.73 | | 2.18 |
| 3 years | 0.73 | | 7.42 |
| 5 years | 0.73 | | 25.4 |
| 10 years | 0.73 | | 309.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Windsor
CEO | Chief Executive Officer | 60 | 2024-03-10 |
| Director of Finance/CFO | 64 | 2024-05-15 | |
Cory Hogaboam
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Reinhard Ambros
BRD | Director/Board Member | 70 | 2013-05-31 |
| Chairman | 71 | 2023-10-30 | |
Brian Windsor
BRD | Director/Board Member | 60 | 2024-03-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/14/25 | Voss Capital LP
| Buy | Company | 104,183 | 0.4424% | |
| 10/24/25 | Voss Capital LP
| Buy | Company | 306,050 | 1.2997% | |
| 9/24/25 | Voss Capital LP
| Other | Company | 1,016,208 | 4.3156% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.98% | -6.81% | -33.57% | -57.13% | 68.61M | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -0.51% | -4.09% | +28.93% | +133.62% | 23.39B | |
| Weighted average by Cap. | +0.23% | -2.96% | +30.78% | +116.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -28.79M -25.03M -23.3M -21.39M -40.39M -2.75B -41.02M -275M -108M -1.37B -108M -106M -4.59B | -36.82M -32.01M -29.79M -27.35M -51.65M -3.51B -52.45M -351M -138M -1.75B -138M -135M -5.87B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$0.7374 | -3.98% | 391,662 |
| 26-07-30 | US$0.7680 | +1.32% | 182,113 |
| 26-07-29 | US$0.7580 | -3.04% | 215,163 |
| 26-07-28 | US$0.7818 | +0.03% | 833,942 |
| 26-07-27 | US$0.7816 | -1.23% | 336,470 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNTX Stock
Select your edition
All financial news and data tailored to specific country editions
